Abstract

Get full access to this article
View all access options for this article.
References
1.
.
Miller
CH
,
Fleischhacker
WW
. Managing antipsychotic-induced acute and chronic akathisia . Drug Saf
2000 ; 22 : 73 –81 . DOI: 10.2165/00002018-200022010-00006
2.
.
Jiménez-Jiménez
FJ
,
García-Ruiz
,
Molina
JA
. Drug-induced movement disorders . Drug Saf
1997 ; 16 : 180 –204 . DOI: 10.2165/00002018-199716030-00004
3.
.
Micheli
F
,
Pardal
MF
,
Gatto
M
, Flunarizine- and cinnarizine-induced extrapyramidal reactions . Neurology
1987 ; 37 : 881 –4 . DOI: 10.1212/WNL.37.5.881
4.
.
Stahl
SM
,
Lonnen
AJ
. The mechanism of drug-induced akathisia . CNS Spectr
2011 Jan 15. pii : Stahl.
5.
.
Barnes
TR
. A rating scale for drug induced akathisia . Br J Psychiatry
1989 ; 154 : 672 –6 . DOI: 10.1192/bjp.154.5.672
6.
.
Naranjo
CA
,
Busto
U
,
Sellers
EM
, A method for estimating the probability of adverse drug reactions . Clin Pharmacol Ther
1981 ; 30 : 239 –45 . DOI: 10.1038/clpt.1981.154
7.
.
Tassone
DM
,
Boyce
E
,
Guyer
J
,
Nuzum
D
. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders . Clin Ther
2007 ; 29 : 26 –48 . DOI: 10.1016/j.clinthera.2007.01.013
8.
.
Li
Z
,
Taylor
CP
,
Weber
M
, Pregabalin is a potent and selective lig- and for α(2)δ-1 and α(2)δ-2 calcium channel subunits . Eur J Pharmacol
2011 ; 667 : 80 –90 . DOI: 10.1016/j.ejphar.2011.05.054
9.
.
Bockbrader
HN
,
Wesche
D
,
Miller
R
,
Chapel
S
,
Janiczek
N
,
Burger
P
. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin . Clin Pharmacokinet
2010 ; 49 : 661 –9 . DOI: 10.2165/11536200-000000000-00000
10.
.
Kim
A
,
Adler
L
,
Angrist
B
,
Rotrosen
J
. Efficacy of low-dose metoprolol in neuroleptic-induced akathisia . J Clin Psychopharmacol
1989 ; 9 : 294 –6 . DOI: 10.1097/00004714-198908000-00012
